IBRN
iShares Neuroscience and Healthcare ETF · PSE
- Category Equity
- Expense Ratio 0.47%
- Listing Date Aug 26, 2022
- Volume 9.0
- Market Cap (AUM) $3.64M
Performance
+2.43%
1W
-1.59%
1M
-6.22%
3M
+17.62%
6M
-7.5%
YTD
-7.35%
1Y
Top Holdings
-
Name
Symbol%Assets
- Neurocrine Biosciences, Inc.NBIX4.98%
- PTC Therapeutics, Inc.PTCT4.89%
- Cerevel Therapeutics Holdings IncCERE4.75%
- Intra-Cellular Therapies, Inc.ITCI4.66%
- Sarepta Therapeutics, Inc.SRPT4.66%
- Axonics, Inc.AXNX4.52%
- Biogen Inc.BIIB4.48%
- argenx SE ADRARGX4.46%
- Xenon Pharmaceuticals Inc.XENE4.15%
- Biohaven Ltd.BHVN3.71%
Technical Analysis of IBRN 2024-05-03
Overview:
In analyzing the technical indicators for IBRN over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible stock price movement in the coming days.
Trend Analysis:
- Moving Averages (MA): The 5-day MA has been trending above the closing prices, indica...
Recent News & Updates
Page 1 of 1
previousnext